Kyle P. Murray

A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity

Natalie A. Finch, Evan J Zasowski, Kyle P. Murray et al. · Antimicrobial Agents and Chemotherapy · 2017 · 235 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin–Tazobactam Compared to Those on Vancomycin and Cefepime

Bhagyashri Navalkele, Jason M. Pogue, Shigehiko Karino et al. · Clinical Infectious Diseases · 2016 · 181 citations · Full text

Medicine, Nephrology, Pharmacotherapy +15

Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study

Kyle P. Murray, Jing Zhao, Susan L. Davis et al. · Clinical Infectious Diseases · 2013 · 175 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin

Evan J Zasowski, Kyle P. Murray, Trang D Trinh et al. · Antimicrobial Agents and Chemotherapy · 2017 · 144 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Prescription Errors Before and After Introduction of Electronic Medication Alert System in a Pediatric Emergency Department

Usha Sethuraman, Nirupama Kannikeswaran, Kyle P. Murray et al. · Academic Emergency Medicine · 2015 · 68 citations · Full text

Medicine, Health Informatics, Pediatrics +14